Related Experiment Video
Updated: Jan 18, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Glycoproteomics analysis of complement factor H and its complement-regulatory function during Streptococcus
Laura M Baas1, Kioa L Wijnsma1, Fokje Zijlstra2
1Department of Pediatric Nephrology, Radboud University Medical Centre, Amalia Children's Hospital, Nijmegen, Netherlands.
Streptococcus pneumoniae infection-associated hemolytic uremic syndrome (SP-HUS) alters complement factor H (FH) glycosylation, but does not impair its function. This study reveals significant changes in FH N-glycans during SP-HUS acute phases.
Area of Science:
- Immunology
- Glycobiology
- Pediatric Nephrology
Background:
- Hemolytic uremic syndrome (HUS) caused by invasive Streptococcus pneumoniae (SP-HUS) is a severe pediatric disease with unclear pathophysiology.
- Complement factor H (FH) regulates the complement system, and its N-glycans may be implicated in SP-HUS pathogenesis.
- Loss of sialic acids on FH N-glycans is hypothesized to impair its function, leading to endothelial damage.
Purpose of the Study:
- To investigate N-glycosylation patterns of FH in SP-HUS patients during acute and remission phases.
- To compare FH glycosylation in SP-HUS patients with healthy controls.
- To assess the functional impact of observed FH glycosylation changes on complement regulation.
Main Methods:
- LC-MS/MS-based glycopeptide profiling was used to analyze FH N-glycosylation at three sites.
- Four SP-HUS patients and healthy controls were included in the comparative analysis.
- Functional assays measured FH's ability to facilitate C3b degradation and prevent complement-mediated hemolysis.
Main Results:
- Significant alterations in FH glycosylation were identified during the acute phase of SP-HUS.
- Increased N-glycans lacking sialic acids, galactose, and N-acetylglucosamine (GlcNAc) were observed in SP-HUS patients compared to controls.
- Despite major glycosylation changes, FH's complement regulatory activity remained unaffected in functional assays.
Conclusions:
- FH N-glycosylation is significantly altered in SP-HUS patients, extending beyond just sialic acid loss.
- These observed N-glycosylation changes do not directly impair the complement regulatory function of FH.
- The study underscores the complex role of N-glycosylation in infection and FH's contribution to complement dysregulation in SP-HUS.
More Related Videos
10:55Assays for Studying the Role of Vitronectin in Bacterial Adhesion and Serum Resistance
Published on: October 16, 2018
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017